CD44 and neoplasm: For this purpose, Nishikawa et al., using CD44 as a stem cell marker, reported that higher expression of CD44 on the periphery of the tumor than in the main mass of the tumor is associated with highly invasive glioblastoma, while lower expression of CD44 on the periphery of the tumor is associated with longer survival [28,29].